Literature DB >> 25194503

Heat shock factor 1 is required for migration and invasion of human melanoma in vitro and in vivo.

Yoshitaka Nakamura1, Mitsuaki Fujimoto2, Sonoko Fukushima3, Akiko Nakamura3, Naoki Hayashida2, Ryosuke Takii2, Eiichi Takaki2, Akira Nakai2, Masahiko Muto3.   

Abstract

Heat shock factor 1 (HSF1) is a major transactivator of the heat shock response. Recent studies have demonstrated that HSF1 is involved in tumor initiation, maintenance, and progression by regulating the expression of heat shock proteins (HSPs) and other molecular targets. Furthermore, HSF1 was identified as a potent proinvasion oncogene in human melanomas. However, the biological functions of HSF1 in human melanoma remain poorly understood. To determine the functional role of HSF1 in melanoma, we used short hairpin RNA (shRNA) to silence HSF1 in human melanoma cell lines and investigated its effect on cell migration and invasive ability in vitro. We found that HSF1 knockdown led to a marked reduction in migration and invasive ability, and these functions were restored by overexpression of wild-type HSF1. To confirm the in vitro results, we performed subcutaneous xenograft experiments in athymic nude mice. We found that HSF1 was required for melanoma invasion and metastasis, as well as tumorigenic potential in vivo. Overall, these results show that HSF1 is indispensable for melanoma progression and metastasis, and suggests that HSF1 could be a promising therapeutic target for melanoma.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Heat shock factor 1 (HSF1); Invasion; Malignant melanoma; Metastasis; Migration

Mesh:

Substances:

Year:  2014        PMID: 25194503     DOI: 10.1016/j.canlet.2014.08.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

Review 1.  The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis.

Authors:  Chengkai Dai
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

Review 2.  A Futile Battle? Protein Quality Control and the Stress of Aging.

Authors:  Ryo Higuchi-Sanabria; Phillip Andrew Frankino; Joseph West Paul; Sarah Uhlein Tronnes; Andrew Dillin
Journal:  Dev Cell       Date:  2018-01-22       Impact factor: 12.270

Review 3.  The Multifaceted Role of HSF1 in Tumorigenesis.

Authors:  Milad J Alasady; Marc L Mendillo
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  HSF1: Guardian of Proteostasis in Cancer.

Authors:  Chengkai Dai; Stephen Byers Sampson
Journal:  Trends Cell Biol       Date:  2015-11-18       Impact factor: 20.808

Review 5.  HSF1 as a Cancer Biomarker and Therapeutic Target.

Authors:  Richard L Carpenter; Yesim Gökmen-Polar
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

Review 6.  Is cancer a disease set up by cellular stress responses?

Authors:  Armando Aranda-Anzaldo; Myrna A R Dent
Journal:  Cell Stress Chaperones       Date:  2021-05-24       Impact factor: 3.667

Review 7.  The Multifaceted Role of HSF1 in Pathophysiology: Focus on Its Interplay with TG2.

Authors:  Luca Occhigrossi; Manuela D'Eletto; Nickolai Barlev; Federica Rossin
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

8.  Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patients.

Authors:  Yuehua Liao; Ying Xue; Lin Zhang; Xinwei Feng; Wanli Liu; Ge Zhang
Journal:  J Transl Med       Date:  2015-10-28       Impact factor: 5.531

9.  The Heat Shock Transcription Factor HSF1 Induces Ovarian Cancer Epithelial-Mesenchymal Transition in a 3D Spheroid Growth Model.

Authors:  Chase D Powell; Trillitye R Paullin; Candice Aoisa; Christopher J Menzie; Ashley Ubaldini; Sandy D Westerheide
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

Review 10.  Adapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in Melanoma.

Authors:  Seyma Demirsoy; Shaun Martin; Hannelore Maes; Patrizia Agostinis
Journal:  Front Oncol       Date:  2016-11-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.